glp 1 and sleep apnea Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review meta-analysis of cardiometabolic and respiratory outcomes Can Losing Weight with GLP-1
Description
CP, chronic pancreatitis
& Wilson, A
Farxiga typically lowers A1C by about 0.8% through its insulin-independent mechanism
Endocrinology , 161
Tirzepatide: Even greater, with average weight loss of 15-22% depending on dose
Lower cost and broader insurance coverage could increase access across communities
